Cti Biopharma Corp

DEUTSCHE BANK AG\

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/15/2023

Shares

61,859

Value ($000)

260

Weight

0.0%

2018 Q2 - 2023 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/15/2023	260	0.0%	61,859	3/31/2023
2022 Q4	2/13/2023	259	0.0%	43,155	12/31/2022
2022 Q3	11/14/2022	247	0.0%	42,493	9/30/2022
2022 Q2	8/11/2022	264	0.0%	44,345	6/30/2022
2022 Q1	5/13/2022	0	0.0%	6	3/31/2022
2021 Q4	2/16/2022	2,407	0.0%	970,435	12/31/2021
2021 Q3	11/4/2021	2,863	0.0%	970,435	9/30/2021
2021 Q2	8/11/2021	2,426	0.0%	970,435	6/30/2021
2021 Q1	5/13/2021	0	0.0%	6	3/31/2021
2020 Q4	2/16/2021	0	0.0%	6	12/31/2020
2020 Q3	11/12/2020	0	0.0%	6	9/30/2020
2020 Q2	8/13/2020	0	0.0%	6	6/30/2020
2018 Q3	12/21/2021	276	—	128,098	9/30/2018
2018 Q2	4/21/2020	488	—	98,014	6/30/2018